Ionis Pharmaceuticals, Inc.
IONS
$55.39
-$0.63-1.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.90% | 59.66% | -78.37% | -204.09% | 184.08% |
| Total Depreciation and Amortization | 2.56% | 1.44% | 63.06% | -17.46% | 1.06% |
| Total Amortization of Deferred Charges | -23.33% | 19.36% | 19.13% | 0.36% | 0.24% |
| Total Other Non-Cash Items | 197.11% | -65.76% | 1,738.30% | -107.26% | 62.28% |
| Change in Net Operating Assets | 183.71% | -3,160.55% | 540.72% | 81.00% | 30.82% |
| Cash from Operations | 171.33% | -475.72% | -4.77% | -186.85% | 200.37% |
| Capital Expenditure | 26.11% | -2.21% | -304.02% | 57.17% | 2.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -92.91% | 240.27% | -512.19% | 189.65% | -158.88% |
| Cash from Investing | -95.62% | 227.97% | -559.29% | 176.07% | -170.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -982,972.73% | 99.98% | -652,807.32% | -2.50% | 4.76% |
| Issuance of Common Stock | -64.65% | -46.85% | 32.68% | 6,213.83% | -42.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -820.06% | -90.31% | 627.89% | 6,413.07% | -43.29% |
| Foreign Exchange rate Adjustments | 63.77% | -220.93% | 47.56% | -113.78% | 156.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 188.84% | -686.34% | -17.35% | 23.93% | 49.73% |